NYSE:GRDNHealthcare
Guardian Pharmacy Services (GRDN): Assessing Valuation After Strong Q3 Results and Upgraded 2025 Outlook
Guardian Pharmacy Services (GRDN) stock saw renewed attention after the company reported a strong third quarter, boosted by a 20% jump in revenue and a notable rise in residents served. Management not only exceeded expectations but also raised their outlook for 2025, highlighting momentum from recent acquisitions in the Pacific Northwest.
See our latest analysis for Guardian Pharmacy Services.
Guardian’s upbeat earnings report and expansion into new markets seem to have supercharged investor...